Privia Health Group, Inc. filed a Form 8-K on August 18, 2026, disclosing that its Board of Directors elected Opella Ernest, M.D. as a Class III director, effective September 1, 2026.
Key Highlights
- New director elected: Opella Ernest, M.D. was elected to Privia Health's Board of Directors as a Class III director, effective September 1, 2026.
- Committee appointment: Dr. Ernest was also appointed as a member of the Board's Compliance Committee, effective September 1, 2026.
- Independence determination: The Board determined Dr. Ernest to be independent under the independence standards of the rules of The Nasdaq Stock Market.
- Equity compensation: Dr. Ernest will receive an annual equity grant of restricted stock units with a grant date fair market value of $200,000 under the 2021 Omnibus Incentive Plan, as amended.
- Pro-rated initial grant: Dr. Ernest will receive an initial grant pro-rated for the number of months she will serve on the Board through the date of the next annual meeting of stockholders.
- No special arrangements: The filing states there are no arrangements or understandings between Dr. Ernest and any other persons pursuant to which she was selected as a director.
Privia Health Board Adds Dr. Opella Ernest as Class III Director
According to the filing, the Board of Directors of Privia Health Group, Inc. (NASDAQ:PRVA) voted on August 12, 2026 to elect Opella Ernest, M.D. to the Board as a Class III director. Her appointment becomes effective September 1, 2026. Simultaneously, the Board appointed Dr. Ernest to serve on the Board's Compliance Committee, also effective September 1, 2026.
The filing states that the Board determined Dr. Ernest to be independent in accordance with the independence standards of the rules of The Nasdaq Stock Market. The company disclosed that "there are no arrangements or understandings between Dr. Ernest and any other persons pursuant to which Dr. Ernest was selected as a director," and that there are no transactions in which she has a direct or indirect material interest requiring disclosure under Item 404(a) of Regulation S-K.
As compensation for her service, the filing indicates Dr. Ernest will receive an annual cash retainer consistent with the Company's Non-Employee Director Compensation Program, along with an annual equity grant of restricted stock units with a grant date fair market value of $200,000 pursuant to the 2021 Omnibus Incentive Plan, as amended. The terms of these grants will be governed by an agreement substantially in the form of the Company's Form of 2021 Omnibus Plan Restricted Stock Unit Award for Non-Employee Directors. A press release announcing the election was issued on August 18, 2026, and is attached to the filing as Exhibit 99.1.
What Was Disclosed
Privia Health Group disclosed the Board election of Opella Ernest, M.D. as a Class III director and Compliance Committee member effective September 1, 2026, along with the terms of her director compensation, including a $200,000 annual restricted stock unit grant.



Please wait processing your request...